CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-09 | Islam Khalid Executive Chairman | Purchase | +50,000 | $1.00 | $50K | 50,000 |
| 2024-07-01 | RICHMAN ERIC I Director | Purchase | +5,000 | $1.23 | $6K | 277,629 |
| 2024-07-01 | RICHMAN ERIC I Director | Purchase | +12,000 | $1.21 | $15K | 289,629 |
| 2024-06-24 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | Melincoff Gwen A Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | Riley Jeffrey Scott Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-24 | RICHMAN ERIC I Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-04-08 | Mack Gene Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-03-28 | Riley Jeffrey Scott Director | Purchase | +30,000 | $3.86 | $116K | 30,000 |
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise | +18,750 | 25,763 | ||
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise | +825 | 26,588 | ||
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise | +637 | 27,225 | ||
| 2024-03-26 | Alder Matthias Chief Executive Officer | Shares withheld for taxes | −6,085 | $4.06 | $25K | 21,140 |
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −18,750 | 56,250 | ||
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −825 | 8,250 | ||
| 2024-03-26 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −637 | 6,376 | ||
| 2024-03-21 | Fuggetta Gianluca See Remark | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 |
Page 2 of 5 · 88 trades